Fortify HNO1 remains on track for year-end enrollment and a mid-2027 interim analysis, but spending will increase.
| Quarter | Q2 FY26 |
|---|---|
| Call date | 2026-08-11 |
| Length | 43 minutes |
| EPS | $-0.82 |
| EPS consensus | $-0.77 |
| Revenue | $4.6M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q4 FY25
Read the full Q2 FY26 earnings call transcript
All BCAX earnings · Back to BCAX overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.